- Joined
- Nov 2, 2019
- Messages
- 3,511
- Reaction score
- 14,571
For totally unrelated reasons, I stumbled across this article:
Challenging the Medical Residency Matching System through Antitrust Litigation
It's a paper published in 2015 talking about a lawsuit brought by residents in 2002 against the AAMC/NRMP/universities/hospitals/literally anyone ever involved in running "the Match".
In brief:
"The resident plaintiffs argued that the organizational and institutional defendants, through the match, had imposed anticompetitive restraints on medical residency placement and hiring by quashing the prospective residents’ ability to negotiate the terms of their employment contracts, resulting in fixed and depressed compensation packages. The legal basis for the residents’ claim was that it violated Section 1 of the Sherman Antitrust Act, which holds that “Every contract…or conspiracy, in restraint of trade or commerce among the several States, or with foreign nations, is declared to be illegal”."
The article is fascinating, and worth a read. However, most fascinating is the sneaky AAMC lobbying where they snuck legislation into the Pension Funding Equity Act of 2004. They introduced an amendment, Section 207. What is Section 207, you ask? It is federal legislation which prevents antitrust lawsuits around the Match.
"On April 8, 2004, Congress passed the Pension Funding Equity Act, and President George W. Bush signed it into law. The Section 207 amendment had two major legal effects. First, the provision confirmed that “it shall not be unlawful under the antitrust laws to sponsor, conduct, or participate in a graduate medical education residency matching program, or to agree to sponsor, conduct, or participate in such a program”. Second, in relation to the first statement, the provision held that “evidence of any of the conduct described…shall not be admissible in Federal court to support any claim or action alleging a violation of antitrust laws”
Obviously, I'm not a lawyer. But I would argue that ASTRO/ADROP/etc making a statement in support of decreasing Radiation Oncology residency spots available through the Match falls under the protection of Section 207, therefore, is exempt from antitrust suits.
I made a post in November with a transcript of the recording where Falit discusses antitrust at ASTRO 2019. In that talk, he makes this specific argument:
"And then the Association of Family Practice Program Directors was also sued by the Justice Department because there was an ostensible agreement between the Practice Directors not to offer more economic incentives for residents to come into the program. And so I think there’s a real risk that if that happened, if there was an agreement within ASTRO or SCAROP or some other organization to restrict residency spots that there would be a lawsuit brought by an aggrieved person or by the Justice Department, and if that happens then I think it actually would be unlikely that the defendant (ASTRO or SCAROP) would be able to even make any pro-competitive arguments."
I looked up the AFPRD case - it's from 1996, eight years before Section 207 was signed into law. It's also a totally different type of case, but that's beside the point.
Perhaps I'm totally wrong, and, if so, I would appreciate any practicing lawyer who can come along and explain why I'm wrong.
But - per the wording of Section 207 of the Pension Funding Equity Act of 2004, ASTRO making the recommendation to reduce spots available through the NRMP-sponsored Match is protected from antitrust suits in Federal Court. I haven't seen this argument made on SDN (or anywhere else) before, so I figured I'd throw this out for discussion.
Challenging the Medical Residency Matching System through Antitrust Litigation
It's a paper published in 2015 talking about a lawsuit brought by residents in 2002 against the AAMC/NRMP/universities/hospitals/literally anyone ever involved in running "the Match".
In brief:
"The resident plaintiffs argued that the organizational and institutional defendants, through the match, had imposed anticompetitive restraints on medical residency placement and hiring by quashing the prospective residents’ ability to negotiate the terms of their employment contracts, resulting in fixed and depressed compensation packages. The legal basis for the residents’ claim was that it violated Section 1 of the Sherman Antitrust Act, which holds that “Every contract…or conspiracy, in restraint of trade or commerce among the several States, or with foreign nations, is declared to be illegal”."
The article is fascinating, and worth a read. However, most fascinating is the sneaky AAMC lobbying where they snuck legislation into the Pension Funding Equity Act of 2004. They introduced an amendment, Section 207. What is Section 207, you ask? It is federal legislation which prevents antitrust lawsuits around the Match.
"On April 8, 2004, Congress passed the Pension Funding Equity Act, and President George W. Bush signed it into law. The Section 207 amendment had two major legal effects. First, the provision confirmed that “it shall not be unlawful under the antitrust laws to sponsor, conduct, or participate in a graduate medical education residency matching program, or to agree to sponsor, conduct, or participate in such a program”. Second, in relation to the first statement, the provision held that “evidence of any of the conduct described…shall not be admissible in Federal court to support any claim or action alleging a violation of antitrust laws”
Obviously, I'm not a lawyer. But I would argue that ASTRO/ADROP/etc making a statement in support of decreasing Radiation Oncology residency spots available through the Match falls under the protection of Section 207, therefore, is exempt from antitrust suits.
I made a post in November with a transcript of the recording where Falit discusses antitrust at ASTRO 2019. In that talk, he makes this specific argument:
"And then the Association of Family Practice Program Directors was also sued by the Justice Department because there was an ostensible agreement between the Practice Directors not to offer more economic incentives for residents to come into the program. And so I think there’s a real risk that if that happened, if there was an agreement within ASTRO or SCAROP or some other organization to restrict residency spots that there would be a lawsuit brought by an aggrieved person or by the Justice Department, and if that happens then I think it actually would be unlikely that the defendant (ASTRO or SCAROP) would be able to even make any pro-competitive arguments."
I looked up the AFPRD case - it's from 1996, eight years before Section 207 was signed into law. It's also a totally different type of case, but that's beside the point.
Perhaps I'm totally wrong, and, if so, I would appreciate any practicing lawyer who can come along and explain why I'm wrong.
But - per the wording of Section 207 of the Pension Funding Equity Act of 2004, ASTRO making the recommendation to reduce spots available through the NRMP-sponsored Match is protected from antitrust suits in Federal Court. I haven't seen this argument made on SDN (or anywhere else) before, so I figured I'd throw this out for discussion.